Bases neurobiológicas del tratamiento de la depresión

Bibliografía básica

Oxford Textbook of Psychiatry. Eds. Gelder M, Gath D, Mayou M. Oxford University Press, Oxford, 1989

Goodman & Gilman’s The Pharmacological Basis of Therapeutics. Eds. Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gilman A. McGraw-Hill, New York, 1996

Psychopharmacology: The Fourth Generation of Progress. Eds. Bloom FE, Kupfer DJ., Lipincott-Raven, New York, 1995

Basic Neurochemistry. Eds. Siegel GJ, Agranoff BW, Albers RW, Molinoff PB (eds) Raven Press, New York, 1994

Antidepressants: New Pharmacological Strategies. Ed. P. Skolnick, Humana Press, Totowa, New Jersey, 1997

SSRIs, Past, Present and Future. Ed. Stanford SC. R.G. Landes Company, Georgetown, Texas, 1999

Principles of Neural Science. Eds. Kandel ER, Schwartz JH, Jessell TM, Appleton & Lange, East Norwalk, Connecticutt, 1991

Fundamental Neuroscience. Eds. Zigmond ME, Bloom FE, Landis SC, Roberts JL, Squire LR. Academic Press, San Diego, 1999

Neurobiology. Ed. Shepherd GM. Oxford University Press, Oxford, 1994

The Neuron: Cellular and Molecular Biology. Eds. Levitan IB, Kaczmarek LK. Oxford University Press, Oxford, 1997

Bibliografía complementaria

Murray CJL, Lopez AD. Alternative prospections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1498-1504

Jacobs BL, Azmitia EC. Structure and function of the brain serotonin system. Physiol. Rev. 1992; 72:165-229

Foote SL, Aston-Jones GS. Pharmacology and physiology of central noradrenergic systems. En Bloom FE Kupfer DJ (eds). Psychopharmacology. The Fourth Generation of Progress. Cap. 29, Lipincott-Raven, New York, 1995.

Siegel GJ, Agranoff BW, Albers RW, Molinoff PB (eds) Basic Neurochemistry, Raven Press, New York, 1994

Bylund DE, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR, Trendelenburg U. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol. Rev. 1994; 46:121-136

Haga T, Haga K, Kameyama K. G-protein-coupled receptor kinases. J. Neurochem. 1994; 63:400-412

Azmitia EC, Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol 1978;179:641-668.

A review of central 5-HT receptors and their function. Neuropharmacology 1999; 38:1083-1152

Blier, P, de Montigny. Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 1994;15:220-226

Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch. Gen. Psychiatry 1990; 47:411-418

Danish University Antidepressant Group . Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Psychopharmacology 1986;90:131-138.

Danish University Antidepressant Group . Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affect Disord 1990;18:289-299.

Richelson E, Nelson A. Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro. J Pharmacol Exp Ther 1984;230:94-102.

Cusack B, Nelson A, Richelson E. Binding of antidepressants to human brain receptors: Focus on newer generation compounds. Psychopharmacology 1994;114:559-565.

Frazer A. Pharmacology of antidepressants. J Clin Psychopharmacol 1997;17:S2-S18.

Artigas F. Selective serotonin/noradrenaline reuptake inhibitors (SNRIs): Pharmacology and therapeutic potential in the treatment of depressive disorders. CNS Drugs 1995;4:79-89.

Sulser F, Vetulani J, Mobley PL. Mode of action of antidepressant drugs. Biochem Pharmacol 1978;27:257-261.

Palvimaki EP, Laakso A, Kuoppamaki M, Syvalahti E, Hietala J. Up-regulation of beta(1)-adrenergic receptors in rat brain after chronic citalopram and fluoxetine treatments. Psychopharmacology 1994;115:543-546.

Nalepa I, Manier DH, Gillespie DD, Rossby SP, Schmidt DE, Sulser F. Lack of beta adrenoceptor desensitization in brain following the dual noradrenaline and serotonin reuptake inhibitor venlafaxine. Eur Neuropsychopharmacol 1998;8:227-232.

Avorn J, Everitt DE, Weiss D. Increased antidepressant use in patients prescribed beta-blockers. JAMA 1986;255:357-360.

Thiessen BQ, Wallace SM, Blackburn JL. Increased prescribing of antidepressants subsequent to ß-blocker therapy. Arch Intern Med 1990;150:2286-2290.

Scuvée-Moreau J, Dresse A. Effect of various antidepressant drugs on the spontaneous firing rate of locur coeruleus and dorsal raphe neurons of the rat. Eur J Pharmacol 1979;57:219-225.

Quinaux N, Scuvée-Moreau J, Dresse A. Inhibition of in vitro and ex vivo uptake of noradrenaline and 5-hydroxytryptamine by five antidepressants; correlation with reduction of spontaneous firing rate of central monoaminergic neurones. Naunyn-Schmied Arch Pharmacol 1982;319:66-70.

Adell A, Artigas F. Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo microdialysis study. Naunyn-Schmied Arch Pharmacol 1991;343:237-244.

Bel N, Artigas F. Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. Eur J Pharmacol 1992;229:101-103.

Celada P, Artigas F. Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat. Naunyn-Schmied Arch Pharmacol 1993;347:583-590.

Mateo Y, Pineda J, Meana JJ. Somatodendritic alpha(2)-adrenoceptors in the locus coeruleus are involved in the in vivo modulation of cortical noradrenaline release by the antidepressant desipramine. J Neurochem 1998;71:790-798.

Hervás I, Artigas F. Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors. Eur J Pharmacol 1998;358:9-18.

Artigas F. 5-HT and antidepressants: new views from microdialysis studies. Trends Pharmacol Sci 1993;14:262.

Artigas F, Romero L, De Montigny C, Blier P. Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Trends Neurosci 1996;19:378-383.

Artigas F, Pérez V, Alvarez E. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry 1994;51:248-251

Blier P, Bergeron R. Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol 1995;15:217-222

Pérez V, Gilaberte I, Faries D, Alvarez E, Artigas F. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment. Lancet 1997;349:1594-1597.

Tomé MB, Isaac MT, Harte R, Holland C. Paroxetine and pindolol: A randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency. Int Clin Psychopharmacol 1997;12:81-89.

Zanardi R, Artigas F, Franchini L, Sforzini L, Gasperini M, Smeraldi E, Pérez J. How long should pindolol be associated with paroxetine to improve the antidepressant response? J Clin Psychopharmacol 1997;17:446-450.

Bordet R, Thomas P, Dupuis B, Reseau de Recherche et d'Experimentation Psychopharmacologique.. Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo- controlled trial. Am J Psychiatry 1998;155:1346-1351.

Zanardi R, Franchini L, Gasperini M, Lucca A, Smeraldi E, Pérez J. Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: a controlled study. J Clin Psychopharmacol 1998;18:441-446

Baker GB, Greenshaw AJ. Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system. Cell. Mol. Neurobiol. 1989; 9:1-44

Caldecott-Hazard S, Morgan DG, DeLeon-Jones F, Overstreet DH, Janowsky D. Clinical and biochemical aspects of depressive disorders: II. Transmitter/Receptor theories. Synapse 1991; 9: 251-301

Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997; 54: 597-606.

Drevets WC, Price JL, Simpson JR, Todd RD, Reich T, Vannier M, Raichle ME. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997; 386:824-827

Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 1996;93:3908-3913.

Sheline YI, Sanghavi M, Mintun MA, Gado MH. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 1999;19:5034-5043